• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SOX9和NM23基因与前列腺癌发病率及预后的相关性

Correlation of SOX9 and NM23 genes with the incidence and prognosis of prostate cancer.

作者信息

Xi Ming, Wan Song, Hua Wei, Zhou Yulin, Jiang Wencong, Hu Jianxin

机构信息

Department of Urology, Huadu District People's Hospital, Southern Medical University, Guangzhou, Guangdong 510530, P.R. China.

Department of Urology, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, P.R. China.

出版信息

Oncol Lett. 2019 Feb;17(2):2296-2302. doi: 10.3892/ol.2018.9828. Epub 2018 Dec 12.

DOI:10.3892/ol.2018.9828
PMID:30675295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6341668/
Abstract

Correlation of sex determining region Y-box (SOX)9 and NM23 genes with the incidence and prognosis of prostate cancer (PC) was investigated. SOX9-small interfering ribonucleic acid (siRNA) and NM23-siRNA were constructed and transfected into PC-3 cells. The expression levels of SOX9 and NM23 messenger RNAs (mRNAs) and proteins in PC-3 cells were detected via reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting. MTT assay was adopted to examine the proliferation ability of the transfected cells, and Transwell assay was applied to detect the migration ability of the transfected cells. Sixty-three patients with PC and 56 patients with benign prostatic hyperplasia who were treated in Huadu District People's Hospital were enrolled. Correlation analyses were conducted for the relative expression levels of SOX9 and NM23 and the Gleason grade; and the survival curves of the patient SOX9/NM23 (S/N) Cq values were plotted. The proliferation and migration abilities of PC-3 cells were remarkably reduced after low expression of SOX9 (P<0.01), while those of PC-3 cells were significantly improved after low expression of NM23 (P<0.01). Compared with that in tissues of PC patients, the relative expression of SOX9 mRNA in patients with benign prostatic hyperplasia was obviously decreased (P<0.01), while that of NM23 mRNA was significantly elevated (P<0.01). The larger the S/N was, the shorter the patient's survival time would be (P<0.05). The low expression of SOX9 gene can significantly reduce the proliferation and migration abilities of PC cells, which is negatively associated with the incidence and prognosis of patients. The low expression of NM23 gene can markedly enhance the proliferation and migration abilities of PC cells, and it is positively related to the incidence and prognosis of patients.

摘要

研究了性别决定区Y盒(SOX)9和NM23基因与前列腺癌(PC)发病率和预后的相关性。构建了SOX9小干扰核糖核酸(siRNA)和NM23-siRNA,并将其转染到PC-3细胞中。通过逆转录定量聚合酶链反应(RT-qPCR)和蛋白质印迹法检测PC-3细胞中SOX9和NM23信使核糖核酸(mRNA)及蛋白质的表达水平。采用MTT法检测转染细胞的增殖能力,采用Transwell法检测转染细胞的迁移能力。纳入了在花都区人民医院接受治疗的63例PC患者和56例良性前列腺增生患者。对SOX9和NM23的相对表达水平与Gleason分级进行相关性分析;绘制患者SOX9/NM23(S/N)Cq值的生存曲线。SOX9低表达后,PC-3细胞的增殖和迁移能力显著降低(P<0.01),而NM23低表达后,PC-3细胞的增殖和迁移能力显著提高(P<0.01)。与PC患者组织相比,良性前列腺增生患者中SOX9 mRNA的相对表达明显降低(P<0.01),而NM23 mRNA的相对表达显著升高(P<0.01)。S/N越大,患者的生存时间越短(P<0.05)。SOX9基因低表达可显著降低PC细胞的增殖和迁移能力,这与患者的发病率和预后呈负相关。NM23基因低表达可显著增强PC细胞的增殖和迁移能力,且与患者的发病率和预后呈正相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/0b216af4c956/ol-17-02-2296-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/77ef47cc2519/ol-17-02-2296-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/3638f278c23d/ol-17-02-2296-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/17f3e590618e/ol-17-02-2296-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/4e6f5b8d3306/ol-17-02-2296-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/bb651227adef/ol-17-02-2296-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/0b216af4c956/ol-17-02-2296-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/77ef47cc2519/ol-17-02-2296-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/3638f278c23d/ol-17-02-2296-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/17f3e590618e/ol-17-02-2296-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/4e6f5b8d3306/ol-17-02-2296-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/bb651227adef/ol-17-02-2296-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c261/6341668/0b216af4c956/ol-17-02-2296-g05.jpg

相似文献

1
Correlation of SOX9 and NM23 genes with the incidence and prognosis of prostate cancer.SOX9和NM23基因与前列腺癌发病率及预后的相关性
Oncol Lett. 2019 Feb;17(2):2296-2302. doi: 10.3892/ol.2018.9828. Epub 2018 Dec 12.
2
Correlation of p16 and nm23-H1 expression levels with incidence and prognosis of soft tissue sarcoma.p16和nm23-H1表达水平与软组织肉瘤发病率及预后的相关性
Oncol Lett. 2019 Jun;17(6):4865-4870. doi: 10.3892/ol.2019.10145. Epub 2019 Mar 13.
3
[Silencing of ezrin gene inhibits proliferation and invasion of human prostate cancer PC-3 cells].埃兹蛋白基因沉默抑制人前列腺癌PC-3细胞的增殖和侵袭
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Jun;32(6):821-4.
4
[Influence of estrogen and progestin on nm23-H1 expression in epithelial ovarian cancer cell lines via activation of phosphorylation signaling].[雌激素和孕激素通过激活磷酸化信号传导对上皮性卵巢癌细胞系中nm23-H1表达的影响]
Zhonghua Fu Chan Ke Za Zhi. 2006 Nov;41(11):756-61.
5
SOXs in human prostate cancer: implication as progression and prognosis factors.SOX 基因在人前列腺癌中的作用:作为进展和预后因素的意义。
BMC Cancer. 2012 Jun 15;12:248. doi: 10.1186/1471-2407-12-248.
6
Oncogenic role of SOX9 expression in human malignant glioma.SOX9 表达在人恶性胶质瘤中的致癌作用。
Med Oncol. 2012 Dec;29(5):3484-90. doi: 10.1007/s12032-012-0267-z. Epub 2012 Jun 20.
7
NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas.NM23基因在人前列腺癌和良性前列腺增生中的表达:联合雄激素阻断治疗的癌组织中表达改变
J Urol. 1996 Jun;155(6):2080-4.
8
Inhibition of nm23-H1 gene expression in chronic myelogenous leukemia cells.慢性粒细胞白血病细胞中nm23-H1基因表达的抑制
Oncol Lett. 2013 Oct;6(4):1093-1097. doi: 10.3892/ol.2013.1500. Epub 2013 Jul 29.
9
Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma.雌莫司汀结合蛋白的免疫组织化学分析,特别关注人前列腺癌中的增殖活性。
Prostate. 1997 Jun 15;32(1):49-58. doi: 10.1002/(sici)1097-0045(19970615)32:1<49::aid-pros7>3.0.co;2-7.
10
Sox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells.Sox9调节人骨肉瘤组织和细胞中Wnt1和Fzd1的过表达。
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4795-805. eCollection 2014.

引用本文的文献

1
Targeting GSK3β and signaling pathways in breast cancer: role of individual members of miR- 23/24/27 cluster.靶向乳腺癌中的糖原合成酶激酶3β及信号通路:miR-23/24/27簇单个成员的作用
BMC Cancer. 2025 Apr 21;25(1):737. doi: 10.1186/s12885-025-14045-8.
2
Aberrant expression of SPAG6 and NM23 predicts poor prognosis of human osteosarcoma.SPAG6和NM23的异常表达预示着人类骨肉瘤的预后不良。
Front Genet. 2022 Sep 19;13:1012548. doi: 10.3389/fgene.2022.1012548. eCollection 2022.
3
Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas.

本文引用的文献

1
Dioxin Exposure in the Manufacture of Pesticide Production as a Risk Factor for Death from Prostate Cancer: A Meta-analysis.农药生产制造过程中的二噁英暴露作为前列腺癌死亡的风险因素:一项荟萃分析。
Iran J Public Health. 2018 Feb;47(2):148-155.
2
An integrative review exploring black men of African and Caribbean backgrounds, their fears of prostate cancer and their attitudes towards screening.一项综合综述,探讨具有非洲和加勒比背景的黑人男性对前列腺癌的恐惧及其对筛查的态度。
Health Educ Res. 2018 Apr 1;33(2):155-166. doi: 10.1093/her/cyy001.
3
Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis.
生长激素型垂体腺瘤中性别决定区 Y 框 9(SOX9)的上调。
BMC Endocr Disord. 2021 Mar 18;21(1):50. doi: 10.1186/s12902-021-00720-x.
4
Exploiting Joint-Resident Stem Cells by Exogenous SOX9 for Cartilage Regeneration for Therapy of Osteoarthritis.通过外源性SOX9利用联合驻留干细胞进行软骨再生以治疗骨关节炎
Front Med (Lausanne). 2021 Feb 12;8:622609. doi: 10.3389/fmed.2021.622609. eCollection 2021.
5
The local and circulating SOX9 as a potential biomarker for the diagnosis of primary bone cancer.局部和循环中的SOX9作为原发性骨癌诊断的潜在生物标志物。
J Bone Oncol. 2020 May 31;23:100300. doi: 10.1016/j.jbo.2020.100300. eCollection 2020 Aug.
6
Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer.SOX9、Wnt/β-连环蛋白和雄激素受体信号在去势抵抗性前列腺癌中的相互作用。
Int J Mol Sci. 2019 Apr 26;20(9):2066. doi: 10.3390/ijms20092066.
阿比特龙和恩杂鲁胺在多西他赛治疗前后的去势抵抗性前列腺癌中的疗效:一项试验水平的荟萃分析。
Prostate Cancer. 2017;2017:8560827. doi: 10.1155/2017/8560827. Epub 2017 Nov 21.
4
Correction: Do psychological harms result from being labelled with an unexpected diagnosis of abdominal aortic aneurysm or prostate cancer through screening? A systematic review.更正:通过筛查被意外诊断为腹主动脉瘤或前列腺癌会导致心理伤害吗?一项系统综述。
BMJ Open. 2018 Jan 21;8(1):e017565corr1. doi: 10.1136/bmjopen-2017-017565corr1.
5
Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer.小分子蛋白磷酸酶 2A 激活剂治疗去势抵抗性前列腺癌。
Cancer Res. 2018 Apr 15;78(8):2065-2080. doi: 10.1158/0008-5472.CAN-17-0123. Epub 2018 Jan 22.
6
miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3β.miR-1301-3p 通过靶向 SFRP1 和 GSK3β 促进前列腺癌干细胞的扩增。
Biomed Pharmacother. 2018 Mar;99:369-374. doi: 10.1016/j.biopha.2018.01.086.
7
Nonmetastatic Castration-resistant Prostate Cancer: A Modern Perspective.非转移性去势抵抗性前列腺癌:现代视角
Urology. 2018 Jun;116:13-16. doi: 10.1016/j.urology.2018.01.010. Epub 2018 Jan 31.
8
Prostate Cancer Lytic Bone Metastases Imaged With 18F-Fluorocholine PET/CT.18F-氟胆碱 PET/CT 成像检测前列腺癌溶骨性骨转移。
Clin Nucl Med. 2018 Mar;43(3):220-221. doi: 10.1097/RLU.0000000000001973.
9
Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.SOX9 在肾细胞癌、膀胱癌和阴茎癌中的表达及临床意义。
Oncol Res Treat. 2017;40(1-2):15-20. doi: 10.1159/000455145. Epub 2017 Jan 25.
10
Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer.ERG和SOX9的免疫组织化学染色作为转移性去势抵抗性前列腺癌患者多西他赛反应的潜在生物标志物。
Oncotarget. 2016 Dec 13;7(50):83735-83743. doi: 10.18632/oncotarget.13407.